IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with

multidrug-resistant tuberculosis, including strength of recommendation, certainty in the evidence, and

relative effects on death and treatment success.

Strong FOR:

 • Bedaquiline

 • Fluoroquinolone: Moxifloxacin, Levofloxacin

Conditional FOR:

 • Linezolid

 • Clofazimine

 • Cycloserine

 • Injectables: Amikacin, Streptomycin

 • Ethambutol

 • Pyrazinamide

 • Injectables: Carbapenems w/ clavulanic acid

 • Delamanid



#MultiDrugResistant #Tuberculosis #MDRTB #management #Treatment #antimicrobials #pharmacology #ebm #idsa